Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew Vaughan Unitt Insider Profile
4 Followers
Andrew Vaughan Unitt, Director at Futura Medical, holds 38.50K shares in Futura Medical (Ticker: GB:FUM).
Andrew Vaughan Unitt has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Andrew Vaughan Unitt's holdings
Insider Roles
Director
Roles that Andrew Vaughan Unitt holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Andrew Vaughan Unitt
Andrew Vaughan Unitt's Trading History
List of latest transactions for each holding click on a transaction to see Andrew Vaughan Unitt's performance on stock
You May Also Like
Andrew Vaughan Unitt insider profile FAQ
What is the percentage of profitable transactions made by Andrew Vaughan Unitt?
The percentage of profitable transactions made by Andrew Vaughan Unitt is ―.
What is the average return per transaction made by Andrew Vaughan Unitt?
The average return per transaction made by Andrew Vaughan Unitt is ―.
What stocks does Andrew Vaughan Unitt hold?
Andrew Vaughan Unitt holds: GB:FUM stocks.
What was Andrew Vaughan Unitt’s latest transaction?
Andrew Vaughan Unitt latest transaction was an Uninformative Buy of 6.16K.
What was Andrew Vaughan Unitt's most profitable transaction?
Andrew Vaughan Unitt’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Andrew Vaughan Unitt's role in Futura Medical?
Andrew Vaughan Unitt's role in Futura Medical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.